C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution HEI Q4 2025 Earnings EPS Beats Estimates Amid Strong Aerospace Demand UHS Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Response RWAYI Q1 2026 Earnings EPS Misses Estimates as Portfolio Adjustments Pressure Results MLCO Q1 2026 Earnings EPS Surges Past Estimates with 81 Surprise PMT Q1 2026 Earnings EPS Misses Estimates Significantly Stock Declines